logo
logo
Sign in

Global Mucosal Atomization Devices Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

avatar
saikiran TBRC
Global Mucosal Atomization Devices Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope

Mucosal atomization devices offer medication through the nostrils. It is known for providing dependable topical solution atomization across the nasal and oropharyngeal mucous membranes. The mucosal atomization devices are used to deliver atomized medication to the mucosal surfaces of the nasal, oral, and larynx, trachea, and lungs.

Sizing and Forecast

The mucosal atomization devices market size has grown strongly in recent years. It will grow from <b>$0.79 billion in 2023 to $0.87 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. </b> The growth in the historic period can be attributed to emergency medicine, anesthesia, pediatric care, pain management, dental procedures.

The mucosal atomization devices market size is expected to see strong growth in the next few years. It will grow to <b>$1.27 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. </b> The growth in the forecast period can be attributed to chronic diseases, telemedicine, precision medicine, cosmetic procedures, patient comfort, autonomous vehicles. Major trends in the forecast period include sustainable and eco-friendly practices, digital mortuary management, green burial options, remote viewing and streaming services, hybrid funeral services.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/mucosal-atomization-devices-global-market-report 

Segmentation & Regional Insights

The mucosal atomization devices market covered in this report is segmented –

1) By Type: Nasal Atomization Devices, Fiber-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices, Bottle Atomizer Devices

2) By Technology: Gas Propelled Atomization Devices, Electrical Atomization Devices

3) By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics

<b>North America</b> was the largest region in the mucosal atomization devices market in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7440&type=smp 

Major Driver Impacting Market Growth

The increase in prevalence of allergic rhinitis across the world propels the growth of the mucosal atomization devices market. Allergic rhinitis refers to a range of symptoms that affect the nose and are brought by breathing allergens such as pollen, dust, or animal dander. Mucosal atomization devices are used to provide budesonide as a topical nasal steroid spray in chronic rhinosinusitis treatment. According to the Allergy Capital Report 2022, one of the most common allergic conditions is seasonal allergic rhinitis, often called hay fever. About 7.7% of adults and 7.2% of children have been diagnosed with seasonal allergic rhinitis in the United States . Therefore, the increasing prevalence of allergic rhinitis across the world drives the growth of the mucosal atomization devices market.

Key Industry Players

Major companies operating in the mucosal atomization devices market include <b> Teleflex Incorporated, DeVilbiss Healthcare LLC, Becton Dickinson and Company, Cook Medical LLC, Medica Holdings LLC, Life-Assist Inc., Pulmodyne Inc., Alcove Manufacturing and Distribution Inc., LMA North America Inc., Medline Industries Inc., Medtronic plc, Smiths Medical Inc., Vyaire Medical Inc., Westmed Inc., Mercury Medical, SunMed LLC, Salter Labs, Armstrong Medical Industries Inc., VBM Medizintechnik GmbH, Intersurgical Ltd., Flexicare Medical Limited, Medovations Inc., Medis Medical Imaging Systems, Medisize BV, Atom Medical Corporation, BLS Systems Limited, Bona Pharma Inc., Central Admixture Pharmacy Services Inc., Dali Medical Devices Co. Ltd., Dynarex Corporation </b>

The mucosal atomization devices market report table of contents includes:


1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis


Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected] 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company 

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany 

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 

Blog: https://blog.tbrc.info/ 

Healthcare Blog: https://healthcareresearchreports.com/ 

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model 

collect
0
avatar
saikiran TBRC
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more